Homepage

[vc_row full_width=”stretch_row” css=”.vc_custom_1640784242154{background-position: 0 0 !important;background-repeat: no-repeat !important;}”][vc_column][ts-custom-heading text=”ABOUT US” font_container=”tag:h2|text_align:center”][vc_row_inner el_class=”ts-two-colum-view” css=”.vc_custom_1645620184305{padding-left: 0px !important;}”][vc_column_inner width=”1/3″ ts_responsive_css=”51671259|colbreak_no|||||||||colbreak_no|||||||||colbreak_no||||||||||colbreak_no|||||||||” css=”.vc_custom_1645620175391{padding-right: 0px !important;}”][ts-iconheadingbox boxstyle=”style-1″ i_type=”ts_labtechco_business_icon” i_icon_ts_labtechco_business_icon=”ts-labtechco-business-icon ts-labtechco-business-icon-flask” h2=”Our Leadership” show_btn=”yes” btn_title=”READ MORE” btn_add_icon=”true” btn_link=”url:%2Fabout-us%2Four-leadership%2F|title:Our%20leadership”]Our Leadership team is composed of seasoned professionals with a strong expertise in the orphan diseases and gene therapy field.[/ts-iconheadingbox][ts-iconheadingbox boxstyle=”style-1″ i_type=”ts_labtechco_business_icon” i_icon_ts_labtechco_business_icon=”ts-labtechco-business-icon ts-labtechco-business-icon-microscope-3″ h2=”Our Board Members” show_btn=”yes” btn_title=”READ MORE” btn_add_icon=”true” btn_link=”url:%2Fabout-us%2Fboard-members%2F|title:Board%20members”]Meet Vivet’s Board of Directors[/ts-iconheadingbox][/vc_column_inner][vc_column_inner width=”1/3″ ts_responsive_css=”73878399|colbreak_no||0||0|||||colbreak_no|||||||||colbreak_no||||||||||colbreak_no|||||||||”][vc_single_image image=”8384″ img_size=”full” alignment=”center” css=”.vc_custom_1649235224721{margin-right: 0px !important;margin-left: 0px !important;padding-right: 0px !important;padding-left: 0px !important;}”][/vc_column_inner][vc_column_inner width=”1/3″ css=”.vc_custom_1645620231262{padding-left: 0px !important;}”][ts-iconheadingbox boxstyle=”style-1″ i_type=”ts_labtechco_business_icon” i_icon_ts_labtechco_business_icon=”ts-labtechco-business-icon ts-labtechco-business-icon-dna-structure” h2=”Our Investors” show_btn=”yes” btn_title=”READ MORE” btn_add_icon=”true” btn_link=”url:%2Finvestors%2F|title:Investors”]Vivet is a private company with strong and committed investors.[/ts-iconheadingbox][ts-iconheadingbox boxstyle=”style-1″ i_type=”ts_labtechco_business_icon” i_icon_ts_labtechco_business_icon=”ts-labtechco-business-icon ts-labtechco-business-icon-earth-globe-1″ h2=”Our Partners” show_btn=”yes” btn_title=”READ MORE” btn_add_icon=”true” btn_link=”url:%2Fabout-us%2Fpartners%2F|title:Partners”]Vivet is working with key and reliable long-term partners.[/ts-iconheadingbox][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row][vc_column][/vc_column][/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1649768164593{background-color: #edeef2 !important;}” el_class=”pipeline-wrapper”][vc_column][ts-custom-heading text=”PIPELINE” font_container=”tag:h2|text_align:center” css=”.vc_custom_1649768200752{padding-top: 30px !important;}”][vc_raw_html]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[/vc_raw_html][vc_row_inner el_class=”pipeline-row” el_id=”pipeline-1″][vc_column_inner width=”1/6″][ts-custom-heading text=”VTX-801″ font_container=”tag:h4|text_align:right”][vc_column_text el_class=”pipeline-phase”]PHASE 3[/vc_column_text][/vc_column_inner][vc_column_inner width=”4/6″][ts-progress-bar values=”%5B%7B%22label%22%3A%22Wilson%E2%80%99s%20disease%22%2C%22value%22%3A%2285%22%2C%22add_icon%22%3A%22true%22%2C%22i_type%22%3A%22fontawesome%22%2C%22i_icon_fontawesome%22%3A%22fa%20fa-ok%22%2C%22i_icon_themify%22%3A%22ti-location-pin%22%2C%22i_icon_sgicon%22%3A%22sgicon%20sgicon-WorldWide%22%2C%22i_icon_vc_linecons%22%3A%22li_star%22%2C%22i_icon_ts_labtechco_business_icon%22%3A%22ts-labtechco-business-icon-nuclear%22%7D%5D”][/vc_column_inner][vc_column_inner width=”1/6″][ts-icon type=”themify” icon_themify=”themifyicon ti-angle-down” color=”bar_blue” size=”sm” el_class=”pipeline_arrow”][ts-single-image alignment=”center”][/vc_column_inner][/vc_row_inner][vc_column_text el_id=”pipeline_text_1″ el_class=”pipeline_text”]

VTX-801 is an AAV-based gene therapy for Wilson’s disease. VTX-801 contains a corrective version of the ATP7B gene, which is malfunctioning in patients affected with Wilson’s disease, and is currently under clinical evaluation in a Phase 1/2 clinical safety and efficacy study (GATEWAY) with a 12-week readout. VTX-801 received US and EU Orphan Drug Designation (ODD), and fast track designation by FDA.

[/vc_column_text][vc_row_inner el_class=”pipeline-row” el_id=”pipeline-2″][vc_column_inner width=”1/6″][ts-custom-heading text=”VTX-802″ font_container=”tag:h4|text_align:right”][vc_column_text el_class=”pipeline-phase”]POC[/vc_column_text][/vc_column_inner][vc_column_inner width=”4/6″][ts-progress-bar values=”%5B%7B%22label%22%3A%22PFIC%202%22%2C%22value%22%3A%2247%22%2C%22add_icon%22%3A%22true%22%2C%22i_type%22%3A%22fontawesome%22%2C%22i_icon_fontawesome%22%3A%22fa%20fa-ok%22%2C%22i_icon_themify%22%3A%22ti-location-pin%22%2C%22i_icon_sgicon%22%3A%22sgicon%20sgicon-WorldWide%22%2C%22i_icon_vc_linecons%22%3A%22li_star%22%2C%22i_icon_ts_labtechco_business_icon%22%3A%22ts-labtechco-business-icon-nuclear%22%7D%5D”][/vc_column_inner][vc_column_inner width=”1/6″][ts-icon type=”themify” icon_themify=”themifyicon ti-angle-down” color=”bar_blue” size=”sm” el_class=”pipeline_arrow”][/vc_column_inner][/vc_row_inner][vc_column_text el_id=”pipeline_text_2″ el_class=”pipeline_text”]VTX-802 is an AAV-based gene therapy for patients with Progressive Familial Intrahepatic Cholestasis Type 2. It delivers a codon-optimized version of the BSEP gene to the liver and is currently under preclinical testing.[/vc_column_text][vc_row_inner el_class=”pipeline-row” el_id=”pipeline-3″][vc_column_inner width=”1/6″][ts-custom-heading text=”VTX-803″ font_container=”tag:h4|text_align:right”][vc_column_text el_class=”pipeline-phase”]PHASE 1/2[/vc_column_text][/vc_column_inner][vc_column_inner width=”4/6″][ts-progress-bar values=”%5B%7B%22label%22%3A%22PFIC%203%22%2C%22value%22%3A%2264%22%2C%22add_icon%22%3A%22true%22%2C%22i_type%22%3A%22fontawesome%22%2C%22i_icon_fontawesome%22%3A%22fa%20fa-ok%22%2C%22i_icon_themify%22%3A%22ti-location-pin%22%2C%22i_icon_sgicon%22%3A%22sgicon%20sgicon-WorldWide%22%2C%22i_icon_vc_linecons%22%3A%22li_star%22%2C%22i_icon_ts_labtechco_business_icon%22%3A%22ts-labtechco-business-icon-nuclear%22%7D%5D”][/vc_column_inner][vc_column_inner width=”1/6″][ts-icon type=”themify” icon_themify=”themifyicon ti-angle-down” color=”bar_blue” size=”sm” el_class=”pipeline_arrow”][/vc_column_inner][/vc_row_inner][vc_column_text el_class=”pipeline_text”]VTX-803 is an AAV-based gene therapy for patients with Progressive Familial Intrahepatic Cholestasis Type 3. It delivers a codon-optimized version of the MDR3 gene to the liver and is currently under preclinical testing/IND enabling studies. VTX-803 received US and EU Orphan Drug Designation (ODD).[/vc_column_text][vc_row_inner el_class=”pipeline-row” el_id=”pipeline-4″][vc_column_inner width=”1/6″][ts-custom-heading text=”VTX-804″ font_container=”tag:h4|text_align:right”][vc_column_text el_class=”pipeline-phase”]POC[/vc_column_text][/vc_column_inner][vc_column_inner width=”4/6″][ts-progress-bar values=”%5B%7B%22label%22%3A%22Citrullinemia%20Type%201%22%2C%22value%22%3A%2247%22%2C%22add_icon%22%3A%22true%22%2C%22i_type%22%3A%22fontawesome%22%2C%22i_icon_fontawesome%22%3A%22fa%20fa-ok%22%2C%22i_icon_themify%22%3A%22ti-location-pin%22%2C%22i_icon_sgicon%22%3A%22sgicon%20sgicon-WorldWide%22%2C%22i_icon_vc_linecons%22%3A%22li_star%22%2C%22i_icon_ts_labtechco_business_icon%22%3A%22ts-labtechco-business-icon-nuclear%22%7D%5D”][/vc_column_inner][vc_column_inner width=”1/6″][ts-icon type=”themify” icon_themify=”themifyicon ti-angle-down” color=”bar_blue” size=”sm” el_class=”pipeline_arrow”][/vc_column_inner][/vc_row_inner][vc_column_text el_id=”pipeline_text_4″ el_class=”pipeline_text”]VTX-804 is an AAV-based gene therapy for patients affected by Citrullinemia Type 1. It delivers a codon-optimized version of the ASS1 gene to the liver and is currently under preclinical testing.[/vc_column_text][vc_row_inner el_class=”pipeline-row” el_id=”pipeline-5″][vc_column_inner width=”1/6″][ts-custom-heading text=”VTX-805″ font_container=”tag:h4|text_align:right”][vc_column_text el_class=”pipeline-phase”]RESEARCH[/vc_column_text][/vc_column_inner][vc_column_inner width=”4/6″][ts-progress-bar values=”%5B%7B%22label%22%3A%22Undisclosed%22%2C%22value%22%3A%2230%22%2C%22add_icon%22%3A%22true%22%2C%22i_type%22%3A%22fontawesome%22%2C%22i_icon_fontawesome%22%3A%22fa%20fa-ok%22%2C%22i_icon_themify%22%3A%22ti-location-pin%22%2C%22i_icon_sgicon%22%3A%22sgicon%20sgicon-WorldWide%22%2C%22i_icon_vc_linecons%22%3A%22li_star%22%2C%22i_icon_ts_labtechco_business_icon%22%3A%22ts-labtechco-business-icon-nuclear%22%7D%5D”][/vc_column_inner][vc_column_inner width=”1/6″][ts-icon type=”themify” icon_themify=”themifyicon ti-angle-down” color=”bar_blue” size=”sm” el_class=”pipeline_arrow”][/vc_column_inner][/vc_row_inner][vc_column_text el_class=”pipeline_text”]Undisclosed.[/vc_column_text][vc_row_inner el_class=”pipeline-row” el_id=”pipeline-8″][vc_column_inner width=”1/6″][ts-custom-heading text=”VTX-806″ font_container=”tag:h4|text_align:right”][vc_column_text el_class=”pipeline-phase”]POC[/vc_column_text][/vc_column_inner][vc_column_inner width=”4/6″][ts-progress-bar values=”%5B%7B%22label%22%3A%22Cerebrotendinous%20Xanthomatosis%22%2C%22value%22%3A%2247%22%2C%22add_icon%22%3A%22true%22%2C%22i_type%22%3A%22fontawesome%22%2C%22i_icon_fontawesome%22%3A%22fa%20fa-ok%22%2C%22i_icon_themify%22%3A%22ti-location-pin%22%2C%22i_icon_sgicon%22%3A%22sgicon%20sgicon-WorldWide%22%2C%22i_icon_vc_linecons%22%3A%22li_star%22%2C%22i_icon_ts_labtechco_business_icon%22%3A%22ts-labtechco-business-icon-nuclear%22%7D%5D”][/vc_column_inner][vc_column_inner width=”1/6″][ts-icon type=”themify” icon_themify=”themifyicon ti-angle-down” color=”bar_blue” size=”sm” el_class=”pipeline_arrow”][/vc_column_inner][/vc_row_inner][vc_column_text el_id=”pipeline_text_3″ el_class=”pipeline_text”]VTX-806 is an AAV-based gene therapy for Cerebrotendinous xanthomatosis (CTX). It delivers a codon-optimized version of the CYP27A1 gene to the liver and is currently under preclinical testing.[/vc_column_text][vc_row_inner el_class=”pipeline-row” el_id=”pipeline-6″][vc_column_inner width=”1/6″][ts-custom-heading text=”VTX-PSM” font_container=”tag:h4|text_align:right|color:%235875b7″][vc_column_text el_class=”pipeline-phase”]POC[/vc_column_text][/vc_column_inner][vc_column_inner width=”4/6″][ts-progress-bar values=”%5B%7B%22label%22%3A%22Sustained%20Expression%22%2C%22value%22%3A%2247%22%2C%22color%22%3A%22bar_blue%22%2C%22add_icon%22%3A%22true%22%2C%22i_type%22%3A%22fontawesome%22%2C%22i_icon_fontawesome%22%3A%22fa%20fa-ok%22%2C%22i_icon_themify%22%3A%22ti-location-pin%22%2C%22i_icon_sgicon%22%3A%22sgicon%20sgicon-WorldWide%22%2C%22i_icon_vc_linecons%22%3A%22li_star%22%2C%22i_icon_ts_labtechco_business_icon%22%3A%22ts-labtechco-business-icon-nuclear%22%7D%5D”][/vc_column_inner][vc_column_inner width=”1/6″][ts-icon type=”themify” icon_themify=”themifyicon ti-angle-down” color=”bar_blue” size=”sm” el_class=”pipeline_arrow”][/vc_column_inner][/vc_row_inner][vc_column_text el_class=”pipeline_text”]VTX-PSM is a non-integrative viral-based technology aimed to allow sustainability of expression in growing organs and tissues. It allows, without integration into the genome, to replicate the transgene during the mitosis. It is currently under preclinical testing.[/vc_column_text][vc_row_inner el_class=”pipeline-row” el_id=”pipeline-7″][vc_column_inner width=”1/6″][ts-custom-heading text=”VTX-PID” font_container=”tag:h4|text_align:right|color:%235875b7″][vc_column_text el_class=”pipeline-phase”]IND ENABLING[/vc_column_text][/vc_column_inner][vc_column_inner width=”4/6″][ts-progress-bar values=”%5B%7B%22label%22%3A%22NAbs%20depletion%22%2C%22value%22%3A%2285%22%2C%22color%22%3A%22bar_blue%22%2C%22add_icon%22%3A%22true%22%2C%22i_type%22%3A%22fontawesome%22%2C%22i_icon_fontawesome%22%3A%22fa%20fa-ok%22%2C%22i_icon_themify%22%3A%22ti-location-pin%22%2C%22i_icon_sgicon%22%3A%22sgicon%20sgicon-WorldWide%22%2C%22i_icon_vc_linecons%22%3A%22li_star%22%2C%22i_icon_ts_labtechco_business_icon%22%3A%22ts-labtechco-business-icon-nuclear%22%7D%5D” el_class=”blue-bar-progress-custom”][/vc_column_inner][vc_column_inner width=”1/6″][ts-icon type=”themify” icon_themify=”themifyicon ti-angle-down” size=”sm” el_class=”pipeline_arrow”][/vc_column_inner][/vc_row_inner][vc_column_text el_id=”pipeline_text_5″ el_class=”pipeline_text”]VTX-PID is a technology aimed to deplete Neutralizing Antibodies (NAbs) levels for a given AAV serotype, to a level allowing proper AAV transduction and therefore desired efficacy. VTX-PID is developed both for patients presenting NAbs because of a previous infection and therefore non eligible for gene therapy; and for patients in need of gene therapy re-administration in case of loss of efficacy.[/vc_column_text][/vc_column][/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1649755495709{background-image: url(https://www.vivet-therapeutics.com/wp-content/uploads/2021/12/Rectangle-30.jpg?id=7812) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column width=”2/3″][/vc_column][vc_column width=”1/3″ css=”.vc_custom_1648127742346{padding-top: 30px !important;padding-right: 50px !important;padding-bottom: 30px !important;padding-left: 50px !important;background-color: #5bc7ef !important;}” el_class=”blue-bloc-home”][ts-heading h2=”OUR INVESTORS” h2_font_container=”font_size:23px|color:%23ffffff|line_height:25px” use_custom_fonts_h2=”true” css=”.vc_custom_1645605294941{border-bottom-width: 25px !important;}”][/ts-heading][ts-heading h2_font_container=”font_size:42px|color:%23184272|line_height:42px” h4=”Strong and Committed Investors” h4_font_container=”font_size:42px|color:%23184272|line_height:42px” use_custom_fonts_h2=”true” use_custom_fonts_h4=”true” css=”.vc_custom_1653916662827{margin-top: 0px !important;margin-bottom: 25px !important;padding-top: 0px !important;}” h2_el_class=”our_investors_1″ h4_el_class=”our_investors_2″]

Vivet Therapeutics has investors from both sides of the ocean, bringing strong support, network and long-term commitment.[/ts-heading][ts-btn title=”READ MORE” style=”outline” shape=”square” color=”primary” link=”url:https%3A%2F%2Fwww.vivet-therapeutics.com%2Finvestors%2F|title:Investors”][/vc_column][/vc_row][vc_row full_width=”stretch_row” css=”.vc_custom_1640787480179{background-color: #ebecf0 !important;}”][vc_column][ts-clientsbox h2=”” show_hover=”no” show_tooltip=”no” column=”four” boxview=”default” el_class=”hp–logos”][/ts-clientsbox][/vc_column][/vc_row][vc_row ts_bgcolor=”white” full_width=”stretch_row”][vc_column zindex=”2″ css=”.vc_custom_1640792878791{background-color: #ffffff !important;}”][ts-testimonialbox h2=”” boxstyle=”style-3″ show=”4″ carousel_dots=”1″ carousel_nav=”hide” carousel_centermode=”1″ css=”.vc_custom_1640792947992{margin-right: 40px !important;margin-left: 40px !important;}”][/ts-testimonialbox][/vc_column][/vc_row][vc_row full_width=”stretch_row” equal_height=”yes” css=”.vc_custom_1659446617274{margin-top: -200px !important;background-color: #184272 !important;background-position: 0 0 !important;background-repeat: no-repeat !important;}” el_class=”pt-200″][vc_column][vc_row_inner el_class=”ts-two-colum-view”][vc_column_inner width=”1/4″][ts-facts-in-digits boxstyle=”style-4″ title=”gene therapy Programs” digit=”5″ interval=”1″ i_type=”ts_labtechco_business_icon” i_icon_ts_labtechco_business_icon=”ts-labtechco-business-icon ts-labtechco-business-icon-nuclear-1″ el_class=”figures-home”][/vc_column_inner][vc_column_inner width=”1/4″][ts-facts-in-digits boxstyle=”style-4″ title=”innovation Technologica Platforms” digit=”2″ interval=”1″ i_type=”ts_labtechco_business_icon” i_icon_ts_labtechco_business_icon=”ts-labtechco-business-icon ts-labtechco-business-icon-atomic” el_class=”figures-home”][/vc_column_inner][vc_column_inner width=”1/4″][ts-facts-in-digits boxstyle=”style-4″ title=”dedicated Employees” digit=”26″ interval=”1″ i_type=”ts_labtechco_business_icon” i_icon_ts_labtechco_business_icon=”ts-labtechco-business-icon ts-labtechco-business-icon-microscope-3″ el_class=”figures-home”][/vc_column_inner][vc_column_inner width=”1/4″][ts-facts-in-digits boxstyle=”style-4″ title=”years of cumulated Experience” digit=”20″ interval=”1″ i_type=”ts_labtechco_business_icon” i_icon_ts_labtechco_business_icon=”ts-labtechco-business-icon ts-labtechco-business-icon-earth-globe” el_class=”figures-home”][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row full_width=”stretch_row”][vc_column][vc_row_inner el_class=”wrapper-title-button”][vc_column_inner][ts-custom-heading text=”NEWS” font_container=”tag:h2|text_align:center” el_class=”titre-home”][ts-btn title=”READ MORE” shape=”square” align=”right” link=”url:%2Fnews%2F|title:News”][/vc_column_inner][/vc_row_inner][ts-blogbox h2=”” boxstyle=”style-3″ category=”news”][/ts-blogbox][/vc_column][/vc_row][vc_row full_width=”stretch_row”][vc_column][vc_row_inner el_class=”wrapper-title-button”][vc_column_inner][ts-custom-heading text=”EVENTS” font_container=”tag:h2|text_align:center” el_class=”titre-home”][ts-btn title=”READ MORE” shape=”square” align=”right” link=”url:%2Fevents%2F|title:Events”][/vc_column_inner][/vc_row_inner][ts-blogbox h2=”” boxstyle=”style-3″ category=”events”][/ts-blogbox][/vc_column][/vc_row][vc_row full_width=”stretch_row_content_no_spaces” content_placement=”middle” css=”.vc_custom_1689802475393{margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;border-bottom-width: 0px !important;padding-top: 230px !important;padding-right: 0px !important;padding-bottom: 220px !important;padding-left: 0px !important;background-image: url(https://www.vivet-therapeutics.com/wp-content/uploads/2023/07/carte-vivet-grise.jpg?id=9252) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” ts_responsive_css=”99983810|colbreak_no|50||50||50||50||colbreak_no|||||||||colbreak_no|||250||230px||220px|||colbreak_no|||||||||”][vc_column css=”.vc_custom_1689802072696{margin-top: -300px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;border-bottom-width: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}”][vc_column_text css=”.vc_custom_1689802009033{margin-top: -200px !important;margin-right: 0px !important;margin-bottom: 0px !important;margin-left: 0px !important;border-bottom-width: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}”]

[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Vivet Therapeutics Privacy Policy

Vivet Therapeutics Cookie Policy[/vc_column_text][/vc_column][/vc_row]